News about Biotechnology

India Emerges as High-Velocity Biopharma Innovation Hub: Endiya Report

India’s biopharma sector gains momentum as policy support, innovation and cost advantages position the country as a global R&D hub.

Biotechnology | 31/03/2026 | By News Bureau |  193

Sobi Advances Tryngolza Expansion with EMA Validation for sHTG

Sobi has announced that the European Medicines Agency (EMA) has validated its application to expand the indication of Tryngolza (olezarsen) for the treatment of adults with severe hypertriglyceridemia (sHTG), defined by triglyceride levels ≥880 mg/dL (≥10 mmol/L).

Biotechnology | 31/03/2026 | By Darshana |  268

NMPA Nod for GSK's Exdensur Boosts Biologics Manufacturing Momentum

GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on maintenance therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and above.

Biotechnology | 31/03/2026 | By Darshana |  138

Eisai and Nuvation Bio Secure EMA Validation for Taletrectinib in Lung Cancer

EU regulator begins review of next-generation targeted therapy for advanced ROS1-positive non-small cell lung cancer.

Biotechnology | 30/03/2026 | By News Bureau |  247

Medtronic Secures FDA Nod for Stealth AXiS, Advancing Integrated Surgical Technology Manufacturing

Medtronic, a global leader in healthcare technology, has received clearance from the US Food and Drug Administration (FDA) for its Stealth AXiS surgical system for use in cranial and ear, nose, and throat (ENT) procedures.

Biotechnology | 30/03/2026 | By Darshana |  122

UK Regulator Pushes Shift Toward Reduced Animal Testing, Issues Roadmap for Alternative Methods

The UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency, has outlined new guidance aimed at reducing reliance on animal testing and accelerating the adoption of alternative scientific methods in drug development.

Biotechnology | 26/03/2026 | By Darshana |  131

Alteogen and Biogen Sign Deal for Hybrozyme-Based Subcutaneous Biologics

Alteogen signs a licensing deal with Biogen to develop and commercialise Hybrozyme-based subcutaneous biologics, granting rights for two products using the ALT-B4 platform.

Biotechnology | 26/03/2026 | By News Bureau |  296

Biocytogen Pharmaceuticals Beijing Partners Moonlight Bio to Advance Next-Generation Cancer Cell Therapies

The strategic collaboration between Biocytogen Pharmaceuticals Beijing and Moonlight Bio aims to combine antibody discovery and cell therapy expertise to develop innovative treatments for hard-to-treat cancers.

Biotechnology | 25/03/2026 | By News Bureau |  185

Co-Diagnostics Expands CoSara's South Asia Footprint, Targets USD 13 Billion Diagnostics Market

Co-Diagnostics, Inc. has announced a strategic expansion of its South Asia operations through its joint venture CoSara Diagnostics Pvt. Ltd., formed in partnership with Ambalal Sarabhai Enterprises Limited.

Biotechnology | 23/03/2026 | By Darshana |  173

From Generics to Biologics: Semaglutide Reshapes Pharma Manufacturing in India

The recent developments around semaglutide in India—triggered by patent expiry and rapid domestic entry—are poised to significantly reshape the country’s pharmaceutical manufacturing landscape.

Biotechnology | 23/03/2026 | By Darshana |  228